Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

<< Previous

Bullboard Posts

Next >>

Post by DrHolidayon Jun 13, 2018 3:49pm

37 Views

Post# 28167768

RBC TD selling generating volume

Once they are finished their sale, and have little left to sell, then the buyside volume will lift the price.
Buyers should thank RBC and TD for this gift, and I know they will be banging their heads against the wall wondering what they were thinking when the sold their stock at such ridiculously low prices.

All those from Missouri, ICO is about to ``show you``

DOC.

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo